Earlobe Crease as Risk Factors of Acute Myocardial Infarction in Chinese Population
NCT ID: NCT02637661
Last Updated: 2016-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
236 participants
OBSERVATIONAL
2015-06-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Earlobe Creases Predict Prognosis in Chinese Patients With Acute Myocardial Infarction
NCT02618681
Optical Coherence Tomography Examination in Acute Myocardial Infarction
NCT03593928
Clinical Features and Linked MEchanisms in Acute Risk-free AMI
NCT06716177
Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
NCT02641184
Clinical Presentations Before AMI Onset and Coronary Atherosclerosis
NCT03107624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objectives:
1. To study the characteristics of different earlobe creases in different gender of the patients with AMI.
2. To analyze the characteristics of earlobe crease in different age groups.
3. To compare the feature of earlobe crease in acute ST elevation myocardial infarction and non ST elevation myocardial infarction.
4. The sensitivity,specificity,positive likelihood ratio and negative likelihood ratio of binaural earlobe crease as risk factors of AMI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Initial AMI
To study the sensitivity, specificity, positive predictive value, and negative predictive value of different earlobe crease as risk factors of AMI
earlobe crease positive
earlobe crease negative
No coronary heart disease
To study the characteristics of earlobe crease
earlobe crease positive
earlobe crease negative
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
earlobe crease positive
earlobe crease negative
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Detection of a rise and/or fall of cardiac biomarker values (preferably cardiac troponin(cTn) with at least one value above the 99th percentile upper reference limit(URL)) and with at least one of the following:
* Symptoms of ischemia
* Development of pathologic Q waves in the electrocardiogram (ECG)
* New or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB).
* Identification of an intracoronary thrombus by angiography or autopsy
* Imaging evidence of new loss of viable myocardium or a new regional wall motion abnormality.
3. Type 1 (spontaneous myocardial infarction(MI)) in the third universal definition of MI: MI consequent to a pathologic process in the wall of the coronary artery (eg, plaque erosion/rupture, fissuring, or dissection), resulting in intraluminal thrombus.
4. Infarct related artery (IRA) showed that acute thrombus formation, IRA occlusion or stenosis ≥95%、≥90%～95%、≤90%，thrombolysis in myocardial infarction(TIMI) 0-3 flow.
5. Signed informed consent.
Exclusion Criteria
2. Previous myocardial infarction.
3. Previous percutaneous coronary intervention(PCI) and coronary artery bypass graft(CABG).
4. Chronic total occlusion(CTO)lesions.
5. Ear malformation.
6. Ocular diseases.
7. Participating in a clinical study.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Hospital of Shenyang Military Region
OTHER
Beihua University
OTHER
Zhejiang Provincial Tongde Hospital
OTHER
Zhejiang Chinese Medical University
OTHER_GOV
Jing Qi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jing Qi
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Junwen Jiang, Doctor
Role: PRINCIPAL_INVESTIGATOR
Liaoning University of Traditional Chinese Medecine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jing
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JQi1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.